Gene · 5469
Papers2,516
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,516
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Mediator subunit MED1 differentially modulates mutant thyroid hormone receptor intracellular dynamics in Resistance to Thyroid Hormone syndrome. | Mol Cell Endocrinol | 2023 | 36191835 | PubTator, text mining | PubMed |
| Role of vitamin D and calcium signaling in epidermal wound healing. | J Endocrinol Invest | 2023 | 35963983 | PubTator, text mining | PubMed |
| BRD4 and MYC: power couple in transcription and disease. | FEBS J | 2023 | 35866356 | PubTator, text mining | PubMed |
| RNAPII response to transcription-blocking DNA lesions in mammalian cells. | FEBS J | 2023 | 35731652 | PubTator, text mining | PubMed |
| Cellular specificity of androgen receptor, coregulators, and pioneer factors in prostate cancer. | Endocr Oncol | 2022 | 37435460 | PubTator, text mining | PubMed |
| Diverse role of androgen action in human breast cancer. | Endocr Oncol | 2022 | 37435447 | PubTator, text mining | PubMed |
| Alternative splicing event associated with immunological features in bladder cancer. | Front Oncol | 2022 | 36686818 | PubTator, text mining | PubMed |
| Analytical approaches to examine gamma-aminobutyric acid and glutamate vesicular co-packaging. | Front Synaptic Neurosci | 2022 | 36685083 | PubTator, text mining | PubMed |
| Afatinib Reverses EMT via Inhibiting CD44-Stat3 Axis to Promote Radiosensitivity in Nasopharyngeal Carcinoma. | Pharmaceuticals (Basel) | 2022 | 36678534 | PubTator, text mining | PubMed |
| Midsize noncoding RNAs in cancers: a new division that clarifies the world of noncoding RNA or an unnecessary chaos? | Rep Pract Oncol Radiother | 2022 | 36632289 | PubTator, text mining | PubMed |
| Vitamin D in Neurological Diseases. | Int J Mol Sci | 2022 | 36613531 | PubTator, text mining | PubMed |
| Correlation between Microvascular Damage and Internal Organ Involvement in Scleroderma: Focus on Lung Damage and Endothelial Dysfunction. | Diagnostics (Basel) | 2022 | 36611347 | PubTator, text mining | PubMed |
Lysophosphatidic acid suppresses apoptosis of high-grade serous ovarian cancer cells by inducing autophagy activity and promotes cell-cycle progression via EGFR-PI3K/Aurora-AThr288-geminin dual signaling pathways. | Front Pharmacol | 2022 | 36601056 | PubTator, text mining | PubMed |
| High Post-Treatment Leptin Concentration as a Prognostic Biomarker of the High Risk of Luminal Breast Cancer Relapse: A Six-Year Comprehensive Study. | Life (Basel) | 2022 | 36556428 | PubTator, text mining | PubMed |
| Multiprotein GLI Transcriptional Complexes as Therapeutic Targets in Cancer. | Life (Basel) | 2022 | 36556332 | PubTator, text mining | PubMed |
| Dysregulation in Multiple Transcriptomic Endometrial Pathways Is Associated with Recurrent Implantation Failure and Recurrent Early Pregnancy Loss. | Int J Mol Sci | 2022 | 36555686 | PubTator, text mining | PubMed |
| Impact of Saccharomyces cerevisiae on the Field of Single-Molecule Biophysics. | Int J Mol Sci | 2022 | 36555532 | PubTator, text mining | PubMed |
| Innate Immune Memory in Monocytes and Macrophages: The Potential Therapeutic Strategies for Atherosclerosis. | Cells | 2022 | 36552836 | PubTator, text mining | PubMed |
| Precision Medicine and Novel Therapeutic Strategies in Detection and Treatment of Cancer: Highlights from the 58th IACR Annual Conference. | Cancers (Basel) | 2022 | 36551698 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5469/papers?page=19